Novo Nordisk A/S ADR buy melinda
Start price
01.09.17
/
50%
€47.74
Target price
29.12.17
€55.00
Performance (%)
13.28%
End price
29.12.17
€54.08
Summary
This prediction ended on 29.12.17 with a price of €54.08. The prediction had a final performance of 13.28%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | -6.415% | -6.415% | -38.614% | -61.098% |
| iShares Core DAX® | -1.410% | 0.471% | 12.651% | 58.522% |
| iShares Nasdaq 100 | -0.450% | -0.305% | 5.495% | 95.184% |
| iShares Nikkei 225® | -0.224% | 5.529% | 18.894% | 49.093% |
| iShares S&P 500 | -1.095% | -0.774% | 1.350% | 60.886% |
According to melinda what are the pros and cons of Novo Nordisk A/S ADR for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Diabetes
Trends Technische Analyse Novo Nordisk A / S
kurzfristig mittelfristig langfristig Trends Trosse Trosse Trosse
(Vom Mitglied beendet)
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€44.70
28.12.25
28.12.25
-
28.12.26
28.12.26
0.22%
03.01.26
03.01.26
Could be worthwhile Investment >10% per year
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€43.06
01.09.17
01.09.17
€49.61
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.95
06.07.17
06.07.17
€45.10
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€32.79
17.01.17
17.01.17
€33.37
24.04.17
24.04.17
2.29%
24.04.17
24.04.17